Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI

NCT06602622 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

108

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV
HIV Associate Weight Loss
HIV-1 Infection
Integrase Inhibitors, HIV; HIV PROTEASE INHIB
Weight Change
Weight Loss

Interventions

DRUG: Integrase inhibitor
DRUG: Doravirine + tenofovir DF + lamivudine

Sponsor

Instituto Mexicano del Seguro Social